STUDY ON THE CURRENT SITUATION OF ANTIBIOTIC USE IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA AT NGHE AN FRIENDSHIP GENERAL HOSPITAL

Nguyễn Văn Tuấn1,
1 Vinh Medical University

Main Article Content

Abstract

Objective: To survey the situation of antibiotic use in the treatment of community-acquired pneumonia at Nghe An friendship general Hospital in 2021. Methods: A cross-sectional descriptive study was performed on 80 patients with community-acquired pneumonia who were treated at Nghe An Friendship General Hospital from January 2021 to April 2021. Results: 60,0% of patients had used antibiotics before entering the hospital. 100% of the patients were given antibiotics immediately upon admission: 82.4% were given a single regimen and 17.6% were prescribed a combination of 2 antibiotics. Initial regimen: The most commonly used antibiotics are β-lactam (63.7%): 3rd generation Cephalosporins (40%) and β-lactams/β-lactamase inhibitors (21.2%). During the treatment process: 32.8% of the initial monotherapy regimen and 30.8% of the initial 2 antibiotic combination regimen had to be changed. The duration of antibiotic use of the majority of patients was 7 – 14 days (83.7%). The average number of days of antibiotic use was 9.48 ± 3.02 days. 35% of the initial regimen and 69.2% of the alternative regimen were consistent with the treatment guidelines of Vietnam's Ministry of Health.Conclusion: Through a study on patients with community-acquired pneumonia showed that a high percentage of patients self-administered antibiotics before hospital admission (60.0%). The average number of days of antibiotic use was 9.48 ± 3.02 days. 35% of the initial regimen and 69.2% of the alternative regimen were consistent with the treatment guidelines of Vietnam's Ministry of Health.

Article Details

References

1. Bộ Y Tế (2020), “Hướng dẫn chẩn đoán và điều trị viêm phổi mắc phải cộng đồng ở người lớn”, tr. 7–45.
2. Nguyễn Thị Hương (2013), “Đánh giá tình hình sử dụng kháng sinh trong điều trị viêm phổi mắc phải ở cộng đồng tại khoa Nội- Bệnh viện đa khoa Quảng Trị”, Đại học Dược Hà Nội.
3. Đỗ Trung Nghĩa (2017), “Phân tích tình hình sử dụng KS trong điều trị viêm phổi mắc phải cộng đồng tại Bệnh viện A tỉnh Thái Nguyên”, Đại học Dược Hà Nội; 2017.
4. Aliberti S, Blasi F, Zanaboni AM, Peyrani P, Tarsia P, Gaito S, et al (2010), “Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia”, Eur Respir J. ; 36(1):128–34.
5. Costa MI, Cipriano A, Santos F V, Valdoleiros SR, Furtado I, Machado A, et al (2020), “Clinical profile and microbiological aetiology diagnosis in adult patients hospitalized with community-acquired pneumonia”, Pulmonology. 2020 Dec.
6. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al (2007), “Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis”; 44(SUPPL. 2).
7. Rivero-Calle I, Pardo-Seco J, Aldaz P, Vargas DA, Mascarós E, Redondo E, et al (2016), “Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project)”, BMC Infect Dis [Internet];16(1):1–8.